Novel inhibitor discovery for influenza virus neuraminidase
A multi-target screening approach connects molecular prediction with in vitro antiviral investigation.
Read the study: Novel inhibitor discovery for influenza virus neuraminidaseExplore the methods, research questions and published work behind Biocentric’s approach to drug discovery.
A multi-target screening approach connects molecular prediction with in vitro antiviral investigation.
Read the study: Novel inhibitor discovery for influenza virus neuraminidaseAn ultra-large library and a known-active comparison put a screening pipeline to the test.
Read the study: Benchmarking a novel in silico pipeline for TYK2 inhibitor discoveryPublications featured by Biocentric. Follow each source for authorship, methods and publication details.
Publication links preserve the original research trail. Findings apply to the methods and conditions described in the source papers.
Bring your target, your challenge, or your next idea. Let’s explore it together.